Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 5,420.00
-50.00 (-0.91%)
Last updated: Jun 4, 2026, 2:24 PM KST
Dongwha Pharm.Co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 18,671 | 8,686 | 5,563 | 27,438 | 20,383 | 17,870 |
Depreciation & Amortization | 22,195 | 21,965 | 19,669 | 13,896 | 12,509 | 12,093 |
Loss (Gain) From Sale of Assets | -9,029 | -9,012 | -21.1 | -28.76 | -741.89 | -169.46 |
Asset Writedown & Restructuring Costs | 152.54 | 146.59 | 321.16 | 491.98 | 3,478 | 316.08 |
Loss (Gain) From Sale of Investments | 804.99 | -454.76 | 6,435 | -9,434 | 4,506 | -1,801 |
Loss (Gain) on Equity Investments | -156.08 | - | 219.37 | -2,420 | 2,269 | 410.4 |
Stock-Based Compensation | 7.52 | 4.95 | -35.91 | 76.11 | - | - |
Provision & Write-off of Bad Debts | 117.64 | 466.66 | -279.92 | 1,117 | 259.2 | -1.17 |
Other Operating Activities | 4,232 | 7,300 | 11,684 | 17,327 | 4,644 | 11,348 |
Change in Accounts Receivable | -3,570 | -1,472 | -12,205 | -4,390 | -5,259 | 1,589 |
Change in Inventory | -15,020 | -17,370 | -21,270 | -12,308 | -14,104 | -1,443 |
Change in Accounts Payable | -2,810 | 2,345 | 5,774 | 2,802 | 5,014 | -1,532 |
Change in Other Net Operating Assets | -2,007 | 3,092 | -19,858 | -5,401 | -3,737 | -2,648 |
Operating Cash Flow | 13,589 | 15,699 | -4,003 | 29,167 | 29,221 | 36,031 |
Operating Cash Flow Growth | - | - | - | -0.18% | -18.90% | -31.01% |
Capital Expenditures | -44,928 | -54,140 | -36,685 | -24,541 | -18,428 | -21,944 |
Sale of Property, Plant & Equipment | 1,452 | 1,426 | 479.17 | 43.34 | 6,520 | 757.12 |
Cash Acquisitions | - | - | - | -18,940 | - | - |
Sale (Purchase) of Intangibles | 7,011 | 6,862 | -37,187 | -1,805 | -1,663 | -2,830 |
Investment in Securities | 2,071 | 4,490 | -1,020 | 48,222 | -28,568 | -1,799 |
Other Investing Activities | -55.87 | 182.31 | -406.59 | -151.67 | -1,022 | 399.81 |
Investing Cash Flow | -34,449 | -41,180 | -74,789 | 2,863 | -43,272 | -25,414 |
Short-Term Debt Issued | - | 67,763 | 30,667 | 2,500 | 2,500 | 2,500 |
Long-Term Debt Issued | - | 9,000 | 27,158 | 16,000 | - | 3,500 |
Total Debt Issued | 108,320 | 76,763 | 57,825 | 18,500 | 2,500 | 6,000 |
Short-Term Debt Repaid | - | -49,080 | -15,455 | -5,000 | -4,500 | -7,800 |
Long-Term Debt Repaid | - | -8,325 | -6,019 | -2,652 | -5,031 | -2,013 |
Total Debt Repaid | -90,208 | -57,405 | -21,474 | -7,652 | -9,531 | -9,813 |
Net Debt Issued (Repaid) | 18,112 | 19,358 | 36,351 | 10,848 | -7,031 | -3,813 |
Dividends Paid | -4,989 | -4,989 | -4,989 | -4,982 | -4,982 | -4,969 |
Other Financing Activities | -595.74 | -969.49 | -5.55 | -0 | - | - |
Financing Cash Flow | 12,527 | 13,399 | 31,356 | 5,866 | -12,013 | -8,783 |
Foreign Exchange Rate Adjustments | -133.56 | -268.56 | 775.32 | 74.95 | -68.24 | 48.76 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | -8,466 | -12,351 | -46,661 | 37,970 | -26,133 | 1,883 |
Free Cash Flow | -31,339 | -38,442 | -40,689 | 4,626 | 10,792 | 14,087 |
Free Cash Flow Growth | - | - | - | -57.14% | -23.39% | -21.66% |
Free Cash Flow Margin | -6.25% | -7.74% | -8.75% | 1.28% | 3.17% | 4.81% |
Free Cash Flow Per Share | -1201.94 | -1386.89 | -1470.08 | 167.09 | 389.91 | 509.78 |
Cash Interest Paid | 3,897 | 3,090 | 268.17 | 28.36 | 165.03 | 166.37 |
Cash Income Tax Paid | 6,213 | 6,854 | 5,182 | 4,825 | 7,780 | 9,513 |
Levered Free Cash Flow | -16,660 | -16,933 | -82,706 | -14,039 | 639.2 | 9,028 |
Unlevered Free Cash Flow | -13,530 | -14,112 | -81,361 | -13,846 | 870.45 | 9,267 |
Change in Working Capital | -23,407 | -13,405 | -47,558 | -19,297 | -18,086 | -4,035 |